InvestorsHub Logo
Followers 59
Posts 17804
Boards Moderated 1
Alias Born 03/17/2004

Re: SSP post# 270512

Wednesday, 02/22/2017 8:44:07 AM

Wednesday, February 22, 2017 8:44:07 AM

Post# of 285887
Speaking of low-priced bios, ARGS -73%. Argos Therapeutics (ARGS) shares plunged 72% in pre-market trade Wednesday, coming off a trading halt, after the company said the independent data monitoring committee recommended a trial for its metastatic renal cell carcinoma treatment be discontinued.

============================================================


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.